Modified Venous Excess Ultrasound (mVExUS) Grades and CA125 Levels in Acute Decompensated Heart Failure

Background and Objectives: Systemic venous congestion is a key feature of acute decompensated heart failure (ADHF). Carbohydrate antigen-125 (CA125) is a biomarker of congestion, whereas venous excess ultrasound provides a noninvasive assessment of systemic venous congestion. We evaluated the association between CA125 and congestion severity assessed by a modified venous excess ultrasound (mVExUS) protocol in patients hospitalized with ADHF. Materials and Methods: This single-center observational study included 112 consecutive patients with ADHF. mVExUS was based on inferior vena cava diameter and hepatic and portal venous Doppler patterns. mVExUS was evaluable in 108 patients, CA125 was available in 106, and 102 had both measurements. The full mVExUS spectrum was examined; grade 3 versus grades 0–2 was used for regression and discrimination analyses. Results: Median CA125 concentrations across mVExUS grades 0, 1, 2, and 3 were 63 (17–210), 61 (20–127), 48.5 (21.5–60), and 151 (88.8–331.8) U/mL, respectively (p < 0.001). Ordinal mVExUS grade correlated with CA125 (ρ = 0.42, p < 0.001). After adjustment for age, sex, eGFR, atrial fibrillation, and severe tricuspid regurgitation, ln (CA125) remained associated with mVExUS grade 3 (adjusted OR 2.73, 95% CI 1.56–4.77; p < 0.001). CA125 showed moderate discrimination for grade 3 congestion (AUC 0.790, 95% CI 0.704–0.873); a threshold of 73 U/mL yielded 80.4% sensitivity and 69.6% specificity. Grade 3 patients also had a longer hospital stay (11 (9–15) vs. 7 (6–12) days; p = 0.001). Conclusions: Higher CA125 levels were associated with severe mVExUS-defined systemic venous congestion. CA125 and mVExUS may provide complementary information, although the derived threshold requires external validation.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2026-11-19
DOI
https://doi.org/10.3390/medicina62112273
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Modified Venous Excess Ultrasound (mVExUS) Grades and CA125 Levels in Acute Decompensated Heart Failure

İrem Müge Akbulut, Gözde Cansu YILMAZ, Tamer Sayın, Volkan Kozluca et al.
Medicina
Heart Failure Treatment and Management
article

Modified Venous Excess Ultrasound (mVExUS) Grades and CA125 Levels in Acute Decompensated Heart Failure

İrem Müge Akbulut, Gözde Cansu YILMAZ, Tamer Sayın, Volkan Kozluca, Mehmet Emre Özerdem, Nail Burak Özbeyaz, Berke Turan Dogan
article en

Abstract

Background and Objectives: Systemic venous congestion is a key feature of acute decompensated heart failure (ADHF). Carbohydrate antigen-125 (CA125) is a biomarker of congestion, whereas venous excess ultrasound provides a noninvasive assessment of systemic venous congestion. We evaluated the association between CA125 and congestion severity assessed by a modified venous excess ultrasound (mVExUS) protocol in patients hospitalized with ADHF. Materials and Methods: This single-center observational study included 112 consecutive patients with ADHF. mVExUS was based on inferior vena cava diameter and hepatic and portal venous Doppler patterns. mVExUS was evaluable in 108 patients, CA125 was available in 106, and 102 had both measurements. The full mVExUS spectrum was examined; grade 3 versus grades 0–2 was used for regression and discrimination analyses. Results: Median CA125 concentrations across mVExUS grades 0, 1, 2, and 3 were 63 (17–210), 61 (20–127), 48.5 (21.5–60), and 151 (88.8–331.8) U/mL, respectively (p < 0.001). Ordinal mVExUS grade correlated with CA125 (ρ = 0.42, p < 0.001). After adjustment for age, sex, eGFR, atrial fibrillation, and severe tricuspid regurgitation, ln (CA125) remained associated with mVExUS grade 3 (adjusted OR 2.73, 95% CI 1.56–4.77; p < 0.001). CA125 showed moderate discrimination for grade 3 congestion (AUC 0.790, 95% CI 0.704–0.873); a threshold of 73 U/mL yielded 80.4% sensitivity and 69.6% specificity. Grade 3 patients also had a longer hospital stay (11 (9–15) vs. 7 (6–12) days; p = 0.001). Conclusions: Higher CA125 levels were associated with severe mVExUS-defined systemic venous congestion. CA125 and mVExUS may provide complementary information, although the derived threshold requires external validation.

MedicinaVol. 62(11)
Ankara University (TR)
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon